Lasa Supergenerics Ltd

Lasa Supergenerics Ltd Share Price Today: Live Updates & Key Insights

Get insights on Lasa Supergenerics Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.

Lasa Supergenerics Ltd Share Price Chart

LASA at 10 Jul 2026 06:15 PM Pharmaceuticals

7.53 +0.10(+1.35%)

Lowest Today 7.15

Highest Today 7.68

Today's Open 7.58

Prev. Close 7.43

52 Week High 19.37

52 Week Low 5.67

Lasa Supergenerics Ltd Fundamentals

Traded Volume: 27,370

Market Cap(Cr): 37.73

Avg Traded Price 7.42

1 Year return -40.57%

Upper Circuit 7.7

Lower Circuit 7.2

P/E TTM -1.00

P/B Ratio 0.751

Traded Value(Cr) 2.06

EPS TTM -6.804

Book value/Share 9.900

Dividend Yield 1Y 0.00%

Lasa Supergenerics Ltd Share Price Performance

Shows the percentage change in stock price over different time periods

This section highlights Lasa Supergenerics Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the Lasa Supergenerics Ltd share price history, short-term movements, long-term trends, and overall investor sentiment

1W +1.48%

1M -1.83%

3M -0.40%

1Y -40.57%

YTD -28.42%

Lasa Supergenerics Ltd Traded Volume Movement

Shows the trading volume over different time periods

This section highlights Lasa Supergenerics Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment

Yesterday 23854.00

Day Before Yesterday 36097.00

1W Avg 25480.60

1M Avg 29006.52

3M Avg 26104.05

Lasa Supergenerics Ltd Technical Details

Lasa Supergenerics Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.

Support 1 7

Support 2 7

Support 3 7

Pivot Point : 7

Resistance 1 8

Resistance 2 8

Resistance 3 8

Lasa Supergenerics Ltd Corporate Actions

Lasa Supergenerics Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on Lasa Supergenerics Ltd’s capital allocation strategies.

All

Ex-Date 16-Sep-2022 Type D Description 0.25/share@2.50% Record Date 19-Sep-2022 Ratio 2.50

Ex-Date 15-Sep-2021 Type D Description 0.25/share@2.50% Record Date - Ratio 2.50

Dividends

Announcement Date 16-Sep-2022 Ex Dividend Date 16-Sep-2022 Dividend(%) 3

Announcement Date 15-Sep-2021 Ex Dividend Date 15-Sep-2021 Dividend(%) 3

Bonus

No Bonus has been declared by LASA

Splits

No Split has been declared by LASA

Others

Rights No Rights has been declared by LASA

Lasa Supergenerics Ltd Peer Comparison

Shows key financial metrics for the company and its peers

This section compares Lasa Supergenerics Ltd with leading peers in the pharmaceuticals & biotechnology sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate Lasa Supergenerics Ltd's relative performance and valuation against major competitors.

Stock Name Sandu Pharmaceuticals Ltd ₹41.00 (+1.06%) M. Cap (Cr) 0.40 1 Yr Return (%) -18.57% P/E (TTM) 16.32 PB Ratio 0.91

Stock Name Goldline Pharmaceutical Ltd ₹41.10 (+0.24%) M. Cap (Cr) 0.39 1 Yr Return (%) NaN% P/E (TTM) 9.59 PB Ratio 2.98

Stock Name Roopa Industries Ltd ₹46.57 (-2.76%) M. Cap (Cr) 0.37 1 Yr Return (%) -23.78% P/E (TTM) 441.55 PB Ratio 2.09

Stock Name Lasa Supergenerics Ltd ₹7.53 (+1.35%) M. Cap (Cr) 0.38 1 Yr Return (%) -40.57% P/E (TTM) -1.11 PB Ratio 0.76

Stock Name Parmax Pharma Ltd ₹91.48 (+2.00%) M. Cap (Cr) 0.34 1 Yr Return (%) +117.81% P/E (TTM) -8.23 PB Ratio -4.99

Stock Name Medi Caps Ltd ₹26.65 (+0.45%) M. Cap (Cr) 0.33 1 Yr Return (%) -38.55% P/E (TTM) -10.95 PB Ratio 0.30

Stock Name Medicamen Organics Ltd ₹22.25 (+0.23%) M. Cap (Cr) 0.27 1 Yr Return (%) -46.51% P/E (TTM) -8.24 PB Ratio 1.05

Lasa Supergenerics Ltd Cash Flow

Cash flow data provides a view of how money is generated and spent by Lasa Supergenerics Ltd, across its operating activities, investing activities, and financing activities.

PARTICULARS Operating Activities Mar 2026 -0.07 Mar 2025 -2.82 Mar 2024 2.14 Mar 2023 -17.30 Mar 2022 10.49

PARTICULARS Investing Activities Mar 2026 0.34 Mar 2025 8.15 Mar 2024 -0.40 Mar 2023 11.19 Mar 2022 -3.25

PARTICULARS Financing Activities Mar 2026 -0.25 Mar 2025 -5.66 Mar 2024 -1.93 Mar 2023 -4.16 Mar 2022 -0.04

PARTICULARS Net Cash Flow Mar 2026 0.01 Mar 2025 -0.33 Mar 2024 -0.19 Mar 2023 -10.27 Mar 2022 7.20

Lasa Supergenerics Ltd Shareholding Pattern

This shows the ownership breakdown of Lasa Supergenerics Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.

Promoter 53.65%

Public 46.35%

Other Institutions 0%

FII N/A%

Mutual Funds N/A%

About Lasa Supergenerics Ltd

Lasa Supergenerics Limited was incorporated on March 11, 2016. The Company is primarily engaged in the business of manufacturing, trading, producing, processing, preparing, treating chemicals, API, Pharmaceuticals, drugs, etc. The Company is a vertically integrated group spanning the entire veterinary, animal and human healthcare value chain-from discovery-to-delivery, with established credentials in research, manufacturing and global marketing. The Company is a veterinary API manufacturing entity, which was acquired in April, 2012. The manufacturing facility is located at Mahad & Chiplun, in the Konkan region of Maharashtra. It specialises in `catalyst chemistry' and manufactures anthelmintic / veterinary API products with largest production capabilities and product categories in India. To efficiently control the supply chain, the Company is fully backward integrated for its key molecules-from discovery research up to full-scale bulk production. The Company's marketing footprint is entrenched across developing markets in multiple countries. Similarly, the group expects to augment its export footprint significantly in width and depth in the future.The Company launched two new block buster products with all-time strong segment, Oxycozanide. Oxyclozanide is an anthelmintic, used in the treatment and control of fascioliasis a topical worm infection in ruminants mainly domestic animals such as cattle, especially buffalos in farm, sheep, and goats. For this, the Company is setting up capacity in a brown field expansion at its Chiplun unit with a total capacity of 20 MT. It got huge demand all over the globe as it is manufactured and have strong entry barriers. The Scheme of Amalgamation of Harishree Aromatics and Chemicals Private Limited with the Company and their respective shareholders was approved by Hon'ble National Company Law Tribunal on December 23, 2022 which became effective from January 04, 2023 in year 2022-23. Following the said Scheme of Amalgamation, 1000 Equity Shares of Rs 10/- per share of the Company was allotted for every 35 Equity Shares of Rs 10/- of Harishree Aromatics and Chemicals Private Limited on January 5, 2023.

Chairman / Executive Director / M D / Promoter

Omkar P Herlekar

Registered office C-105 MIDC, Mahad, Raigad, Maharashtra, 402301

FAX :91-2145-232101/232202

Background

Incorporation Year 2016

Face Value ₹10.00

Market Lot 1

Lasa Supergenerics Ltd Latest News

VIEW MORE NEWS

FAQs on Lasa Supergenerics Ltd